Ohio § 4729.291

§ 4729.291.

(A) Except when provided under section 4731.97 of the Revised Code , when a licensed health professional authorized to prescribe drugs personally furnishes

drugs to a patient pursuant to division (B) of section 4729.29 of the Revised Code , the prescriber shall ensure that the drugs are labeled and packaged in accordance

with state and federal drug laws and any rules and regulations adopted pursuant to

those laws.  Records of purchase and disposition of all drugs personally furnished to patients

shall be maintained by the prescriber in accordance with state and federal drug statutes

and any rules adopted pursuant to those statutes. (B) When personally furnishing to a patient RU-486 (mifepristone), a prescriber is subject

to sections 2919.123 and 2919.124 of the Revised Code . (C)(1) Except as provided in divisions (D) and (E) of this section, no prescriber shall

do either of the following: (a) In any thirty-day period, personally furnish to or for patients, taken as a whole,

controlled substances in an amount that exceeds a total of two thousand five hundred

dosage units; (b) In any seventy-two-hour period, personally furnish to or for a patient an amount

of a controlled substance that exceeds the amount necessary for the patient's use

in a seventy-two-hour period. (2) The state board of pharmacy may impose a fine of not more than five thousand dollars

on a prescriber who fails to comply with the limits established under division (C)(1)

of this section.  A separate fine may be imposed for each instance of failing to comply with the limits.  In imposing the fine, the board's actions shall be taken in accordance with Chapter

119. of the Revised Code. (D) None of the following shall be counted in determining whether the amounts specified

in division (C)(1) of this section have been exceeded: (1) Methadone personally furnished to patients for the purpose of treating drug dependence

or addiction, if the prescriber meets the conditions specified in 21 C.F.R. 1306.07 ; (2) Buprenorphine personally furnished to patients for the purpose of treating drug dependence

or addiction as part of an opioid treatment program licensed under section 5119.37 of the Revised Code . (3) Controlled substances personally furnished to research subjects by a facility conducting

clinical research in studies approved by a hospital-based institutional review board

or an institutional review board accredited by the association for the accreditation

of human research protection programs. (E) Division (C)(1) of this section does not apply to a prescriber who is a veterinarian.